Anahita Nejatfard

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Infectious Diseases

Dna Methylation

Hyaluronic Acid

Inflammatory Response

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ben S Ou, Julie Baillet, Vittoria C T M Picece, Emily C Gale, Abigail E Powell, Olivia M Saouaf, Jerry Yan, Anahita Nejatfard, Hector Lopez Hernandez, Eric A Appel
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines. ACS nano 18 (4) (2024)
Ben S Ou, Julie Baillet, Vittoria C T M Picece, Emily C Gale, Abigail E Powell, Olivia M Saouaf, Jerry Yan, Anahita Nejatfard, Hector Lopez Hernandez, Eric A Appel
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines. ACS nano 18 (4) (2024)
Ben S Ou, Julie Baillet, Vittoria C T M Picece, Emily C Gale, Abigail E Powell, Olivia M Saouaf, Jerry Yan, Anahita Nejatfard, Hector Lopez Hernandez, Eric A Appel
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines. ACS nano 18 (4) (2024)
Ben S Ou, Julie Baillet, Vittoria C T M Picece, Emily C Gale, Abigail E Powell, Olivia M Saouaf, Jerry Yan, Anahita Nejatfard, Hector Lopez Hernandez, Eric A Appel
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines. ACS nano 18 (4) (2024)
Ben S Ou, Julie Baillet, Vittoria C T M Picece, Emily C Gale, Abigail E Powell, Olivia M Saouaf, Jerry Yan, Anahita Nejatfard, Hector Lopez Hernandez, Eric A Appel
Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines. ACS nano (2024)